Production (Stage)
Beta Bionics, Inc.
BBNX
$14.43
-$1.08-6.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -28.66M | -18.11M | -- | -12.45M | |
| Total Depreciation and Amortization | 604.00K | 529.00K | -- | 563.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 14.55M | 6.54M | -- | 4.62M | |
| Change in Net Operating Assets | -6.47M | -3.24M | -- | -4.88M | |
| Cash from Operations | -19.98M | -14.28M | -- | -12.14M | |
| Capital Expenditure | -333.00K | -561.00K | -- | -406.00K | |
| Sale of Property, Plant, and Equipment | -- | 0.00 | -- | 50.00K | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -178.79M | -29.10M | -- | 8.00M | |
| Cash from Investing | -179.12M | -29.66M | -- | 7.64M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 211.12M | 38.00K | -- | 6.00K | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | 59.66M | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -2.81M | -- | -- | |
| Cash from Financing | 211.12M | 56.89M | -- | 6.00K | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 12.02M | 12.95M | -- | -4.49M | |